Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Not Just Catching Up: How India Can Democratize Gene and Cell Therapies

Summary by sciencechronicle.in
NexCAR19, approved in 2023, is India’s first home-grown CAR-T cell therapy for blood cancers. NexCAR19 is not an isolated success story. Indian institutions are working on gene and cell therapies for haemophilia A, sickle cell disease, and age-related macular degeneration (AMD)
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

sciencechronicle.insciencechronicle.in

Not Just Catching Up: How India Can Democratize Gene and Cell Therapies

NexCAR19, approved in 2023, is India’s first home-grown CAR-T cell therapy for blood cancers. NexCAR19 is not an isolated success story. Indian institutions are working on gene and cell therapies for haemophilia A, sickle cell disease, and age-related macular degeneration (AMD)

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

sciencechronicle.in broke the news in on Tuesday, July 22, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

India icon

India

You have read 1 out of your 5 free daily articles.

News
For You
SearchBlindspotLocal